Latest market price
41.02
-0.17-0.41%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -1.87 | Insider Own | 28.52% | Shs Outstand | 77.40M | Perf Week | -8.63% |
| Market Cap | 3.19B | Forward P/E | — | EPS next Y | -1.07 | Insider Trans | -0.46% | Shs Float | 71.77M | Perf Month | -11.40% |
| Enterprise Value | 2.85B | PEG | — | EPS next Q | -0.58 | Short Float | 16.20% | Perf Quarter | -23.88% | ||
| Income | -138.00M | P/S | 3.42 | EPS this Y | — | Short Ratio | 9.47 | Perf Half Y | -25.18% | ||
| Sales | 931.00M | P/B | 6.38 | EPS next Y | — | ROA | -6.88% | Short Interest | 11.63M | Perf YTD | -42.13% |
| Book/sh | 6.46 | P/C | 5.69 | EPS next 5Y | — | ROE | -26.78% | 52W High | 99.90 -58.94% | Perf Year | -30.20% |
| Cash/sh | 7.24 | P/FCF | — | EPS past 3/5Y | — | ROIC | 36.10% | 52W Low | 39.65 3.47% | Perf 3Y | 273.77% |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | 42.14% 51.00% | Gross Margin | 47.85% | Volatility | 4.22% 4.13% | Perf 5Y | -36.64% |
| Dividend TTM | — | EV/Sales | 3.07 | EPS Y/Y TTM | — | Oper. Margin | -14.32% | ATR (14) | 2.03 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 0.68 | Sales Y/Y TTM | 54.91% | Profit Margin | -14.87% | RSI (14) | 33.45 | Recom | 3.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 0.68 | EPS Q/Q | 6.67% | SMA20 | -8.55% | Beta | 2.00 | Target Price | 66.00 |
| Payout | 0.00% | Debt/Eq | 0.45 | Sales Q/Q | 67.07% | SMA50 | -13.51% | Rel Volume | 1.02 | Prev Close | 41.19 |
| Employees | 1,282 | LT Debt/Eq | 0.45 | Earnings | Nov 05 | SMA200 | -29.25% | Avg Volume | 1.04M | Price | 41.02 |
| IPO Date | Jul 02, 2020 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 0.76% 1.16% | Net Debt/EBITDA | — | Volume | 1,067,974 | Change | -0.41% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-06-26 | Reiterated | Morgan Stanley | Equal Weight | $56 → $48 |
| Aug-19-26 | Reiterated | Morgan Stanley | Equal Weight | $75 → $56 |
| Jul-30-26 | Upgrade | Keefe, Bruyette & Woods | Underperform → Market Perform | |
| Jul-15-26 | Reiterated | Piper Sandler | Neutral | $65 → $75 |
| Jul-08-26 | Downgrade | Morgan Stanley | Overweight → Equal Weight | $80 → $75 |
| May-21-26 | Reiterated | UBS | $80 → $75 | |
| May-08-26 | Reiterated | Morgan Stanley | Overweight | $85 → $80 |
| Mar-17-26 | Upgrade | Morgan Stanley | Equal Weight → Overweight | |
| Feb-24-26 | Reiterated | Wolfe Research | Underperform | $44 |
| Feb-19-26 | Reiterated | Piper Sandler | Neutral | $85 → $65 |
Latest News· Times ET
Today
Oct-29-26
Oct-29-2611:06AM
Oct-27-26
Oct-22-26
Oct-20-26
Oct-19-26
Oct-16-26
Oct-16-2608:09PM
Oct-13-26
Oct-12-26
Oct-08-26
08:19AM
Oct-06-26
Oct-06-2607:22PM
08:26AM
Lemonade Expands Renters Insurance to Hawaiiprnewswire.com
Oct-02-26
Oct-01-26
Company
Lemonade, Inc. functions as an insurance provider operating across the United States and Europe, offering a diverse array of policies. Their core coverage options encompass protection against stolen or damaged personal property, as well as personal liability insurance designed to safeguard customers if they are deemed responsible for accidents or harm to others or their assets. Specifically, they provide renters, homeowners, pet, auto, life, and landlord insurance products. Additionally, the company extends its services by acting as an agent for other insurance carriers. Founded in 2015 as Lemonade Group, Inc., the New York-headquartered firm later adopted its current name, Lemonade, Inc.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 931 | 738 | 527 | 430 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 486 | 441 | 354 | 340 | — | — | — | — | — | |
| Gross Profit | 446 | 297 | 173 | 90 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 433 | 364 | 291 | 231 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 146 | 94 | 86 | 89 | — | — | — | — | — | |
| Operating Income | -134 | -161 | -204 | -230 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | -134 | -161 | -204 | -230 | — | — | — | — | — | |
| Income Taxes | 5 | 5 | -2 | 7 | — | — | — | — | — | |
| Consolidated Net Income | -138 | -165 | -202 | -237 | — | — | — | — | — | |
| Net Income From Continuing Operations | -138 | -165 | -202 | -237 | — | — | — | — | — | |
| Net Income | -138 | -165 | -202 | -237 | — | — | — | — | — | |
| EPS (Recurring) | -1.87 | -2.30 | -2.85 | -3.40 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -1.87 | -2.30 | -2.85 | -3.40 | — | — | — | — | — | |
| EPS (Diluted) | -1.87 | -2.30 | -2.85 | -3.40 | — | — | — | — | — | |
| EBITDA | -122 | -146 | -184 | -210 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.39 | 6.94 | 4.94 | 2.63 | — | — | — | — | — | |
| Gross Margin | 47.91 | 40.24 | 32.83 | 20.93 | — | — | — | — | — | |
| Operating Margin | -14.39 | -21.82 | -38.71 | -53.49 | — | — | — | — | — | |
| Net Margin | -14.82 | -22.36 | -38.33 | -55.12 | — | — | — | — | — | |
| Shares Outstanding | 77 | 72 | 71 | 70 | — | — | — | — | — | |
| Market Capitalization | 3,159 | 5,125 | 2,604 | 1,129 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Peters John Sheldon | Chief Insurance Officer | Sep 04 '26 | Sale | 54.45 | 2,249 | 122,458 | 73,834 | Sep 08 |
| BIXBY TIMOTHY E | Chief Financial Officer | Sep 03 '26 | Sale | 54.63 | 1,893 | 103,415 | 172,370 | Sep 08 |
| Prosor Maya | Chief Business Officer | Sep 03 '26 | Sale | 54.63 | 1,040 | 56,815 | 186,533 | Sep 08 |
| Peters John Sheldon | Chief Insurance Officer | Sep 03 '26 | Sale | 54.63 | 859 | 46,927 | 76,083 | Sep 08 |
| Peters John Sheldon | Chief Insurance Officer | Aug 13 '26 | Sale | 52.55 | 11,000 | 578,050 | 76,942 | Aug 17 |
| BIXBY TIMOTHY E | Chief Financial Officer | Jul 07 '26 | Sale | 79.18 | 73,000 | 5,780,140 | 174,263 | Jul 09 |
| Peters John Sheldon | Chief Insurance Officer | Jul 06 '26 | Sale | 79.00 | 3,444 | 272,076 | 77,942 | Jul 08 |
| Peters John Sheldon | Chief Insurance Officer | Jun 04 '26 | Sale | 52.94 | 3,608 | 191,008 | 81,386 | Jun 05 |
| Prosor Maya | Chief Business Officer | Jun 03 '26 | Sale | 53.17 | 1,220 | 64,867 | 187,573 | Jun 05 |
| BIXBY TIMOTHY E | Chief Financial Officer | Jun 03 '26 | Sale | 53.17 | 2,227 | 118,410 | 247,263 | Jun 05 |
| Peters John Sheldon | Chief Insurance Officer | Jun 03 '26 | Sale | 53.17 | 1,735 | 92,250 | 84,994 | Jun 05 |
| Angelidis-Smith Maria | Director | Mar 10 '26 | Buy | 55.55 | 8,740 | 485,478 | 38,944 | Mar 30 |
| Peters John Sheldon | Chief Insurance Officer | Mar 04 '26 | Sale | 52.50 | 3,571 | 187,478 | 76,729 | Mar 05 |
| Peters John Sheldon | Chief Insurance Officer | Mar 03 '26 | Sale | 50.12 | 1,773 | 88,863 | 80,300 | Mar 05 |
| BIXBY TIMOTHY E | Chief Financial Officer | Mar 03 '26 | Sale | 50.12 | 2,135 | 107,006 | 249,490 | Mar 05 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.